5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 26.15▲ | 26.18▼ | 26.27▼ | 26.29▼ | 26.09▲ |
MA10 | 26.15▲ | 26.26▼ | 26.31▼ | 26.26▼ | 25.96▲ |
MA20 | 26.19▼ | 26.31▼ | 26.33▼ | 26.09▲ | 25.78▲ |
MA50 | 26.29▼ | 26.31▼ | 26.29▼ | 25.92▲ | 25.75▲ |
MA100 | 26.29▼ | 26.25▼ | 26.12▲ | 25.78▲ | N/A |
MA200 | 26.25▼ | 26.07▲ | 26.01▲ | 25.73▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.026▼ | -0.025▼ | 0.009▲ | 0.058▲ |
RSI | 31.532▼ | 30.640▼ | 31.496▼ | 54.398▲ | 60.475▲ |
STOCH | 58.333 | 10.865▼ | 33.978 | 73.087 | 80.483▲ |
WILL %R | 0.000▲ | -88.679▼ | -88.679▼ | -44.601 | -28.539 |
CCI | 113.675▲ | -110.627▼ | -226.626▼ | -12.612 | 157.531▲ |
Thursday, September 11, 2025 06:01 AM
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN Bioinductive Implant ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
18/09/25 | 26.125 | 26.155 | 26.125 | 26.155 | 59,138 |
17/09/25 | 26.39 | 26.4086 | 26.295 | 26.31 | 212,315 |
16/09/25 | 26.33 | 26.37 | 26.33 | 26.34 | 214,617 |
15/09/25 | 26.3319 | 26.36 | 26.32 | 26.32 | 272,993 |
12/09/25 | 26.30 | 26.31 | 26.19 | 26.30 | 452,800 |
11/09/25 | 26.28 | 26.35 | 26.28 | 26.31 | 274,404 |
10/09/25 | 26.23 | 26.285 | 26.20 | 26.23 | 198,200 |
09/09/25 | 26.22 | 26.245 | 26.19 | 26.19 | 273,408 |
08/09/25 | 26.22 | 26.26 | 26.21 | 26.26 | 171,198 |
05/09/25 | 26.19 | 26.20 | 26.15 | 26.15 | 182,869 |
|
|
||||
|
|
||||
|
|